Washington Trust Advisors, Inc. Novartis Ag Transaction History
Washington Trust Advisors, Inc.
- $1.15 Billion
- Q4 2024
A detailed history of Washington Trust Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Washington Trust Advisors, Inc. holds 346 shares of NVS stock, worth $38,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
346
Previous 699
50.5%
Holding current value
$38,796
Previous $80,000
58.75%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding NVS
# of Institutions
1,478Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.37 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.24 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$918 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$770 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$625 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $241B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...